United States · FDA National Drug Code directory
Arformoterol Tartrate Inhalation Solution
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76204-026_459f97a4-5026-29d1-e063-6294a90a1a9a
- Product NDC
- 76204-026
- Form
- SOLUTION
- Composition / generic term
- Arformoterol Tartrate Inhalation Solution
- Labeler
- Ritedose Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230227
- Source listing expiry
- 20261231
Source-listed ingredients
- ARFORMOTEROL TARTRATE — 15 ug/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 POUCH in 1 CARTON (76204-026-01) / 1 AMPULE in 1 POUCH / 2 mL in 1 AMPULE · 76204-026-01
- 60 POUCH in 1 CARTON (76204-026-02) / 1 AMPULE in 1 POUCH / 2 mL in 1 AMPULE · 76204-026-02
- 12 POUCH in 1 CARTON (76204-026-55) / 5 AMPULE in 1 POUCH / 2 mL in 1 AMPULE · 76204-026-55
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →